Amgen – Amgen Inc. stock outperforms competitors despite losses on the day
Shares of Amgen Inc.
shed 0.78% to $223.94 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index
falling 1.31% to 3,819.72 and Dow Jones Industrial Average
falling 0.39% to 31,270.09. This was the stock’s second consecutive day of losses. Amgen Inc. closed $52.75 short of its 52-week high ($276.69), which the company reached on January 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson
fell 1.76% to $156.22, Roche Holding AG Part. Cert.
fell 1.31% to $327.17, and Pfizer Inc.
rose 2.63% to $34.39. Trading volume (2.6 M) eclipsed its 50-day average volume of 2.5 M.